GURUFOCUS.COM » STOCK LIST » Asia » China » SZSE » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » 5-Year Yield-on-Cost %
Switch to:

China National Accord Medicines (SZSE:000028) 5-Year Yield-on-Cost %

: 2.57 (As of Today)
View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's yield on cost for the quarter that ended in Mar. 2023 was 2.57.

The historical rank and industry rank for China National Accord Medicines's 5-Year Yield-on-Cost % or its related term are showing as below:

SZSE:000028' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.49   Med: 1.36   Max: 6.96
Current: 2.57

During the past 13 years, China National Accord Medicines's highest Yield on Cost was 6.96. The lowest was 0.49. And the median was 1.36.

SZSE:000028's 5-Year Yield-on-Cost % is ranked worse than
59.38% of 64 companies
in the Medical Distribution industry
Industry Median: 3.15 vs SZSE:000028: 2.57

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines 5-Year Yield-on-Cost % Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's 5-Year Yield-on-Cost % falls in comparison to its industry or sector. The grey bar indicates the 5-Year Yield-on-Cost %'s extreme value range as defined by GuruFocus.

China National Accord Medicines 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of China National Accord Medicines is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

China National Accord Medicines  (SZSE:000028) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

China National Accord Medicines 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's 5-Year Yield-on-Cost % provided by Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

China National Accord Medicines logo
Traded in Other Exchanges
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines